LifeStance Health Group (NASDAQ:LFST) Lowered to “Buy” Rating by Wall Street Zen

Wall Street Zen cut shares of LifeStance Health Group (NASDAQ:LFST) from a strong-buy rating to a buy rating in a research report report published on Saturday.

Other analysts also recently issued research reports about the company. The Goldman Sachs Group initiated coverage on LifeStance Health Group in a research report on Friday, June 5th. They issued a “neutral” rating and a $9.00 price objective for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of LifeStance Health Group in a research report on Wednesday, May 27th. KeyCorp raised their price target on shares of LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Barclays boosted their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Finally, Canaccord Genuity Group raised their target price on LifeStance Health Group from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, LifeStance Health Group has an average rating of “Moderate Buy” and an average price target of $11.50.

LifeStance Health Group Stock Up 0.8%

Shares of NASDAQ LFST opened at $10.90 on Friday. The stock has a market capitalization of $4.23 billion, a P/E ratio of 181.67 and a beta of 1.12. LifeStance Health Group has a one year low of $3.74 and a one year high of $11.76. The firm’s 50 day simple moving average is $9.33 and its two-hundred day simple moving average is $7.82. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.48 and a quick ratio of 1.48.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.03. The firm had revenue of $403.48 million during the quarter, compared to analyst estimates of $387.46 million. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The firm’s revenue was up 21.2% on a year-over-year basis. As a group, analysts expect that LifeStance Health Group will post 0.12 EPS for the current fiscal year.

Insider Buying and Selling at LifeStance Health Group

In related news, Director Robert Bessler sold 894,337 shares of the company’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $10.13, for a total value of $9,059,633.81. Following the completion of the transaction, the director owned 539,763 shares of the company’s stock, valued at approximately $5,467,799.19. This represents a 62.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Darren M. Black sold 5,899,661 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $47,315,281.22. Following the sale, the director owned 23,310,115 shares of the company’s stock, valued at $186,947,122.30. This represents a 20.20% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 7,687,394 shares of company stock worth $63,579,701. 3.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On LifeStance Health Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LFST. Assetmark Inc. boosted its stake in LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after purchasing an additional 1,367 shares during the period. Park Edge Advisors LLC lifted its position in LifeStance Health Group by 14.4% during the 4th quarter. Park Edge Advisors LLC now owns 11,863 shares of the company’s stock worth $84,000 after acquiring an additional 1,495 shares during the period. California State Teachers Retirement System grew its stake in shares of LifeStance Health Group by 1.6% in the 4th quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock valued at $885,000 after purchasing an additional 1,966 shares during the last quarter. Vident Advisory LLC grew its stake in shares of LifeStance Health Group by 12.7% in the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock valued at $112,000 after purchasing an additional 2,447 shares during the last quarter. Finally, Xponance LLC increased its holdings in shares of LifeStance Health Group by 26.4% in the fourth quarter. Xponance LLC now owns 13,144 shares of the company’s stock valued at $93,000 after purchasing an additional 2,745 shares during the period. Institutional investors own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.